triparanol has been researched along with Leukemia P388 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuks, Z; Glaubiger, D; Ramu, A | 1 |
1 other study(ies) available for triparanol and Leukemia P388
| Article | Year |
|---|---|
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
Topics: Animals; Cell Division; Cell Survival; Doxorubicin; Drug Resistance; Estradiol; Leukemia P388; Leukemia, Experimental; Mice; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen; Triparanol | 1984 |